Skip to content
Clinical Trials – home

Vas-Oxy Kft.

Verified siteinfo

Hungary Vizonto Utca 7/b, 9700 Szombathely, Hungary

  • 3 trials recruiting
  • Arteriosclerosis · Chronic obstructive pulmonary disease · Colitis ulcerative
  • Adult patients

About Specializations

Vas-Oxy Kft. in Szombathely, Hungary specialises in clinical trials of conditions such as Arteriosclerosis, Chronic obstructive pulmonary disease, Colitis ulcerative, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology, focusing on innovative treatments for ulcerative colitis. The center's research is dedicated to improving the quality of life for patients with moderately to severely active ulcerative colitis through advanced therapeutic approaches.

  • Ulcerative Colitis
  • Inflammatory Bowel Disease
  • Clinical Remission Induction

By exploring the efficacy of novel agents like RO7790121, the center contributes significantly to the development of effective induction therapies, aiming to achieve clinical remission and enhance patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Vizonto Utca 7/b9700 SzombathelyHungary
Recruiting now
3 trials
Conditions studied
5
Partner status
Verified site

More sites in SzombathelyHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Colitis ulcerative

Not recruiting

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.